Han Huihui, Wei Wanyi, Duan Weisong, Guo Yansu, Li Yi, Wang Jie, Bi Yue, Li Chunyan
Department of Neurology, The Second Hospital of Hebei Medical University, 215 Heping West Road, Shijiazhuang, 050000, Hebei Province, China.
In Vitro Cell Dev Biol Anim. 2015 Mar;51(3):249-63. doi: 10.1007/s11626-014-9832-4. Epub 2014 Nov 11.
Autophagy-linked FYVE (Alfy) is a protein implicated in the selective degradation of aggregated proteins. In our present study, we found that Alfy was recruited into the aggregated G93A-SOD1 in transgenic mice with amyotrophic lateral sclerosis (ALS). We demonstrated that Alfy overexpression could decrease the expression of mutant proteins via the autophagosome-lysosome pathway, and thereby, the toxicity of mutant proteins was reduced. The clearance of the mutant proteins in NSC34 cells was significantly inhibited in an Alfy knockdown cellular model. We therefore deduced that Alfy translocalization likely is involved in the pathogenesis of ALS. Alfy may be developed into a useful target for ALS therapy.
自噬相关的FYVE结构域蛋白(Alfy)是一种与聚集蛋白的选择性降解有关的蛋白质。在我们目前的研究中,我们发现Alfy在患有肌萎缩侧索硬化症(ALS)的转基因小鼠中被募集到聚集的G93A - SOD1中。我们证明Alfy的过表达可以通过自噬体 - 溶酶体途径降低突变蛋白的表达,从而降低突变蛋白的毒性。在Alfy敲低细胞模型中,NSC34细胞中突变蛋白的清除受到显著抑制。因此,我们推断Alfy的易位可能参与了ALS的发病机制。Alfy可能会被开发成为ALS治疗的一个有用靶点。